Morgan Keegan & Company, Inc. v. John Garrett, et

495 F. App'x 443
CourtCourt of Appeals for the Fifth Circuit
DecidedOctober 23, 2012
Docket11-20736
StatusUnpublished
Cited by6 cases

This text of 495 F. App'x 443 (Morgan Keegan & Company, Inc. v. John Garrett, et) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Morgan Keegan & Company, Inc. v. John Garrett, et, 495 F. App'x 443 (5th Cir. 2012).

Opinion

PER CURIAM: *

A group of eighteen investors (collectively, “Appellants”) alleged that Defendant-Appellee Morgan Keegan & Company, Inc. (“Morgan Keegan”) engaged in a fraudulent scheme that induced Appellants to invest substantially in four highly risky mutual funds that Morgan Keegan managed and sold (the “Funds”). Accordingly, Appellants brought claims before an arbitration panel of the Financial Industry Regulatory Authority (“FINRA”) pursuant to the Texas Securities Act and for statutory and common-law fraud. The arbitration panel ultimately issued an award in Appellants’ favor. Morgan Keegan moved to vacate the award and Appellants moved to confirm. The district court vacated the award and granted Morgan Keegan attorneys’ fees and expenses. The court based its decision on a finding that either the award was procured by fraud, or, alternatively, that the arbitration panel exceeded its powers. Because we conclude that these holdings were in error, we REVERSE and REMAND with instructions to enter judgment enforcing the arbitration award.

I. Facts and Procedural History

In their Second Amended Statement of Claims, Appellants alleged that Morgan Keegan “misleadingly and intentionally overvalued assets held by the Funds and used principal from the Funds to pay purported dividends to maintain the illusion that the investments were sound, making the [Fjunds essentially operate as a ‘Ponzi’ scheme.” In addition, Appellants asserted that Morgan Keegan “not only made false representations in selling the Funds to the public and in their Prospectus and Registration Statements filed with the Securities and Exchange Commission, [but] they also falsely reported asset values and made false representations regarding the Funds’ earnings and dividends to (1) ensure that investors would not redeem their shares and (2) induce investors to reinvest declared dividends into shares of the Funds.” Moreover, Morgan Keegan allegedly gave the fraudulent information to its own brokers/financial advisors with the intention that it be disseminated to and relied upon by clients/investors, such as Appellants, to reassure them falsely of the Funds’ net asset values and safety despite the ongoing collapse of the housing and credit markets, and to induce further investments in the Funds.

Appellants further asserted that only when Hyperion Brookfield Asset Management, Inc. purchased the Funds and conducted an audit of the Funds’ assets did they learn of Morgan Keegan’s fraudulent scheme. By that time, however, Appellants had lost substantially all of their capital investments in the Funds. As a result, on February 6, 2009, Appellants brought claims before FINRA pursuant to the Texas Securities Act and for statutory and common-law fraud. 1 Thereafter, both *445 parties signed a FINRA Arbitration Submission Agreement with respect to Appellants’ suit (the “FINRA Submission Agreement”),

Before the final arbitration hearing, Morgan Keegan filed motions in the arbitration proceeding to declare the claims at issue not subject to FINRA arbitration. Specifically, Morgan Keegan alleged that Appellants’ claims were derivative claims, and therefore not subject to FINRA arbitration. In addition, Morgan Keegan argued that Appellants William C. Goodwin (“Goodwin”) and J. Stephen Harris (“Harris”) were not “customers” of Morgan Kee-gan so there was no binding agreement to arbitrate their claims. The arbitrators rejected Morgan Keegan’s arguments, and the arbitration continued.

At the final arbitration hearing, Dr. Craig McCann (“Dr. McCann”), a securities analyst, provided expert testimony on Appellants’ behalf. Dr. McCann testified to, inter alia, his calculations of the percentage of losses in the Funds attributable to losses on the Funds’ internally-priced securities that Morgan Keegan had allegedly deliberately overpriced. The arbitration panel issued an award in Appellants’ favor.

Approximately one week later, Dr. McCann testified in the related Arispe arbitration regarding the Funds’ losses due to internally-priced securities. In that proceeding, however, Dr. McCann testified to different numbers than he had testified to in the earlier Garrett arbitration. In doing so, Dr. McCann explained that one of his staff members had failed to account for certain internally-priced securities in the calculations, and that correcting the mistakes had generated different numbers. In addition, Dr. McCann asserted that he had learned of the errors after giving his testimony in the Garrett arbitration. It is undisputed that Dr. McCann’s corrected numbers were provided to Morgan Keegan (through the same lawyers) in conjunction with the Arispe arbitration almost two weeks before the award issued in Garrett.

After the arbitration panel issued the award, Morgan Keegan commenced the instant action by filing a motion to vacate the arbitration award. Appellants then moved for an order confirming the award. The two actions were consolidated in the district court. After a hearing and extensive briefing, the district court entered an order vacating the arbitration award. According to the district court’s opinion, the arbitrators had exceeded their authority because (1) the panel heard claims from Goodwin and Harris, with whom Morgan Keegan had no agreement to arbitrate, and (2) Appellants’ claims were derivative claims and therefore were not subject to FINRA arbitration. Morgan Keegan & Co. v. Garrett, 816 F.Supp.2d 439, 441-42 (S.D.Tex.2011). Alternatively, the district court vacated the award on the ground that it was procured by fraud because Dr. McCann had knowingly testified to incorrect numbers, and “the [arbitration] panel based its damages calculations on [Dr. McCann’s] knowingly false testimony.” Id. at 442. Appellants timely appealed the district court’s order.

After prevailing on its motion to vacate the arbitration award, Morgan Keegan moved for an award of attorneys’ fees and expenses incurred in the district court proceedings from all Appellants except Goodwin and Harris pursuant to the Attorneys’ *446 Fees Provision contained in the Morgan Keegan Client Agreements (the “Attorneys’ Fees Provision”). The district court granted Morgan Keegan’s motion, and awarded $150,000 in attorneys’ fees and $11,374.06 in expenses. Appellants timely filed a supplemental notice of appeal of the district court’s order vacating the arbitration award, and its order granting attorneys’ fees and expenses.

II. DISCUSSION

A. Order Vacating the Arbitration Award

This court “review[s] de novo the vaca-tur of an arbitration award.” Citigroup Global Mkts., Inc. v. Bacon, 562 F.3d 349, 350 (5th Cir.2009). “Judicial review of an arbitration award is extraordinarily narrow....” Antwine v. Prudential Bache Sec., Inc., 899 F.2d 410, 413 (5th Cir.1990). It is also “exceedingly deferential.” Brabham v. A.G. Edwards & Sons Inc., 376 F.3d 377

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
495 F. App'x 443, Counsel Stack Legal Research, https://law.counselstack.com/opinion/morgan-keegan-company-inc-v-john-garrett-et-ca5-2012.